http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3539151-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcb88e6c103e4974b104452c51fbb4a5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D315-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J23-868
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D315-00
filingDate 1985-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a90b8132ec70f8104ef7a0278e81ee1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c690f48f7cacfcbe299c693308ec52f7
publicationDate 1986-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-3539151-A1
titleOfInvention METHOD AND PRODUCTION OF EPSILON-BUTYROLACTONE BY CATALYTIC HYDRATION OF MALEIC ACID, FUMARIC ACID AND / OR AMERIC ACID ESTER
abstract For the preparation of gamma -butyrolactone, esters of maleic acid, fumaric acid or succinic acid or mixtures thereof are hydrogenated in the presence of copper chromite catalysts, preferably barium-containing copper chromite catalysts, in the trickle phase at a hydrogen pressure of 1 to 12 bar and temperatures of 180 to 260 DEG C.
priorityDate 1984-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3065243-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2553761-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2602894-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11770311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13611234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449935281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5369200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448899939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426082406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5355457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410498268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415745645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531076

Total number of triples: 41.